Richard Davies wrote: The UK has a good crop of technology pioneers in cloud computing - for example ElasticHosts, FlexiScale, Flexiant, OnApp - and also some strong government initiatives such as G-Cloud.
We will have to see whether this kind of technical leadership converts into swift mass-market adoption or not.
SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- AMN Healthcare Services, Inc. (NYSE: AHS) today announced operating results for the second quarter of 2010. Financial highlights are as follows:
(Dollars in millions, except per share amounts)
% Chg % Chg
Q2 Q2 Q1
2010 2009 2010
Revenue $149.3 (25%) 4%
Gross Profit $41.2 (23%) 3%
Net Income $0.1 (97%) (82%)
Diluted Earnings
per Share $0.00 NM NM
Cash Flow from
Operations $6.8 (81%) (42%)
Adjusted EBITDA* $9.7 (46%) (7%)
Adjusted EPS* $0.02 (88%) NM
* See notes (2) and (3) under "Supplemental Financial and Operating
Data" for a reconciliation of non-GAAP items.
NM - Not meaningful
Key business highlights for the second quarter are as follows:
Revenues were up 4% sequentially, compared with guidance of 1 to 3%
Locum Tenens and Physician Permanent Placement revenues were both sequentially up 8%
Nurse and Allied revenues were sequentially flat
SG&A levels as a percentage of revenues remain steady, excluding acquisition-related costs
"The industry appears to be entering a modest recovery phase, with second quarter consolidated revenues growing sequentially for the first time in seven quarters, and exceeding our expectations due to better than anticipated volumes," said Susan R. Nowakowski, President and Chief Executive Officer of AMN Healthcare. "Although we are experiencing positive indicators and steady progress, we retain a conservative view of the near-term trajectory for healthcare staffing due to the continued high general unemployment and apprehension in the economic environment. We continue to be positive about the industry's long-term growth prospects and are positioning our service offerings to meet the strategic needs of our clients and their growth and financial objectives."
In support of its long-term strategy, AMN Healthcare announced earlier today that it has entered into a definitive agreement to acquire the parent company of Nursefinders, Inc. (dba Medfinders), the nation's leading provider of clinical workforce managed services programs. Through its multi-brand strategy, Medfinders also provides travel nurse and allied staffing, locum tenens, physician search services, and home healthcare services, as well as local nurse and allied staffing in support of its managed services programs. The transaction is expected to close in the third quarter of 2010, and additional details of the agreement can be found in a separate press release issued today.
"This acquisition is a natural step in our long-term growth strategy as it directly contributes to the delivery of greater value and innovative workforce solutions to our clients. In addition to enhancing the capabilities of our existing businesses and expanding into new complementary service lines, we will also be able to achieve immediate sales and operating efficiencies. We believe this is the perfect addition to AMN to enhance shareholder value in both the short and long term," added Nowakowski.
Second Quarter 2010 Results
For the second quarter of 2010, revenue was $149 million, a decrease of 25% from prior year and up 4% from prior quarter. Second quarter revenue for the Nurse and Allied staffing segment was $76 million, a decrease of 32% from the same quarter last year and up 1% sequentially. The Locum Tenens staffing segment generated revenue of $65 million, a decrease of 17% from prior year and up 8% sequentially. Second quarter Physician Permanent Placement revenue was $8 million, a decrease of 7% from prior year and up 8% sequentially.
Gross margin in the second quarter of 2010 was 27.6%, an increase of 60 bps from prior year and a decrease of 30 bps compared to the previous quarter. The improvement as compared to the prior year was driven primarily by an increase in gross margin in the Nurse and Allied segment and the increased revenue mix from the higher margin Physician Permanent Placement segment. The decrease as compared to prior quarter was mainly attributable to a decrease in Nurse and Allied gross margin.
Selling, general and administrative ("SG&A") expenses for the second quarter of 2010 were 23% as a percentage of revenue compared to 19% in the same quarter last year. Second quarter SG&A declined by $3 million, or 9%, over the same period in the prior year, and increased by $3 million, or 8%, as compared to the prior quarter, due in part to acquisition-related costs incurred during the quarter.
As of June 30, 2010, cash and cash equivalents totaled $41 million, compared to $27 million as of December 31, 2009. Total term debt outstanding, net of discount, as of June 30, 2010 was $104 million, with no borrowings on the revolver portion of the credit facility.
Business Trends and Outlook
Going into the third quarter, demand continues to trend up slightly across all business lines. With all business segments anticipating sequential improvement in volumes, consolidated revenue is expected to be up 4-6% compared with the second quarter, excluding the impact of any acquisitions. Gross margin is anticipated to remain sequentially steady.
About AMN Healthcare Services
AMN Healthcare Services, Inc. is the nation's largest provider of comprehensive healthcare staffing and workforce solutions. As a leading provider of travel nurse and allied staffing services, locum tenens (temporary physician staffing) and physician permanent placement services, AMN Healthcare recruits and places healthcare professionals on assignments of variable lengths and in permanent positions with clients throughout the United States, ranging from acute-care hospitals and physician practice groups to other healthcare settings. AMN Healthcare also offers flexible, customized workforce management solutions to healthcare organizations through its managed services program and recruitment process outsourcing services. For more information, visit http://www.amnhealthcare.com.
Conference Call on July 29, 2010
AMN Healthcare Services, Inc.'s second quarter 2010 conference call will be held on Thursday, July 29, 2010, at 9:00 a.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at http://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 553-0326 in the U.S. or (612) 332-0720 internationally. A telephonic replay of the call will be available at 11:00 a.m. Eastern Time on July 30, 2010, and can be accessed until 11:59 p.m. Eastern Time on August 19, 2010, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 163114. Alternatively, a replay of the webcast will be available at the company's website at 11:00 a.m. Eastern Time on July 30, 2010.
Non-GAAP Measures
This earnings release contains certain non-GAAP financial information. These measures are not in accordance with, or an alternative to, generally accepted accounting principles in the United States ("GAAP"), and may be different from non-GAAP measures reported by other companies. From time to time, additional information regarding non-GAAP financial measures may be made available on the company's website at http://www.amnhealthcare.com/investors.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding third quarter demand, revenue and gross margin, the industry's growth prospects and company's positioning, the proposed acquisition's enhancement of the company's existing capabilities and expansion into complementary service lines and its impact on sales and operating efficiencies and on shareholder value. The company based these forward-looking statements on its current expectations and projections about future events. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press release are set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2009 and its other quarterly and periodic reports filed with the SEC. These statements reflect the company's current beliefs and are based upon information currently available to it. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated with the passage of time.
Important Information
AMN Healthcare intends to file a proxy statement and other relevant materials with the SEC to obtain shareholder approval of (i) the convertibility of the preferred stock to be issued to Medfinders' shareholders in the acquisition into shares of AMN Healthcare common stock and (ii) the voting rights of such preferred stock (the "Stockholder Approval"). INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER RELEVANT MATERIALS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE STOCKHOLDER APPROVAL. The proxy statement, any amendments or supplements to the proxy statement and other relevant documents filed by AMN Healthcare with the SEC will be available free of charge through the web site maintained by the SEC at www.sec.gov or by calling the SEC at telephone number 1-800-SEC-0330. Free copies of these documents may also be obtained from AMN Healthcare's website at www.amnhealthcare.com or by writing to: AMN Healthcare Services, Inc., 12400 High Bluff Drive, Suite 100, San Diego, California 92130, Attention: Investor Relations.
AMN Healthcare and its directors and executive officers are deemed to be participants in the solicitation of proxies from the stockholders of AMN Healthcare in connection with the Stockholder Approval. Information regarding AMN Healthcare's directors and executive officers is included in AMN Healthcare's definitive proxy statement for its 2010 annual meeting of stockholders held on April 14, 2010, which was filed with the SEC on March 12, 2010. Other information regarding the participants in such proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the proxy statement to be filed in connection with the Stockholder Approval.
Contact:
Amy C. Chang
Vice President, Investor Relations
866.861.3229
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Operations
(dollars in thousands, except per share amounts)
(unaudited)
Three Months Ended Six Months Ended
------------------ ----------------
June 30, March 31, June 30,
-------- --------- --------
2010 2009 2010 2010 2009
---- ---- ---- ---- ----
Revenue $149,282 $199,140 $143,294 $292,576 $448,735
Cost of revenue 108,111 145,463 103,250 211,361 331,075
------- ------- ------- ------- -------
Gross profit 41,171 53,677 40,044 81,215 117,660
------ ------ ------ ------ -------
27.6% 27.0% 27.9% 27.8% 26.2%
Operating expenses:
Selling, general
and
administrative 34,594 37,840 31,950 66,544 87,920
23.2% 19.0% 22.3% 22.7% 19.6%
Depreciation
and
amortization 3,163 3,442 3,298 6,461 6,909
Impairment
and
restructuring
charges - 2,152 - - 180,777
--- ----- --- --- -------
Total
operating
expenses 37,757 43,434 35,248 73,005 275,606
------ ------ ------ ------ -------
Income (loss)
from operations 3,414 10,243 4,796 8,210 (157,946)
2.3% 5.1% 3.3% 2.8% (35.2%)
Interest expense,
net 2,583 2,320 2,637 5,220 4,519
----- ----- ----- ----- -----
Income
(loss)
before
income
taxes 831 7,923 2,159 2,990 (162,465)
Income tax expense
(benefit) 694 3,549 1,379 2,073 (45,005)
--- ----- ----- ----- -------
Net income
(loss) $137 $4,374 $780 $917 $(117,460)
==== ====== ==== ==== =========
0.1% 2.2% 0.5% 0.3% (26.2%)
Net income (loss)
per common share:
Basic $0.00 $0.13 $0.02 $0.03 $(3.60)
===== ===== ===== ===== ======
Diluted $0.00 $0.13 $0.02 $0.03 $(3.60)
===== ===== ===== ===== ======
Weighted average
common shares
outstanding:
Basic 32,760 32,621 32,631 32,696 32,599
====== ====== ====== ====== ======
Diluted 33,566 32,918 33,471 33,519 32,599
====== ====== ====== ====== ======
AMN Healthcare Services, Inc.
Supplemental Financial and Operating Data
(dollars in thousands, except per share amounts and operating data)
(unaudited)
Three Months Ended Six Months Ended
------------------ ----------------
June 30, March 31, June 30,
-------- -------- --------
2010 2009 2010 2010 2009
Revenue
Nurse and
allied
healthcare
staffing $75,606 $111,136 $75,191 $150,796 $274,986
Locum
tenens
staffing 65,348 79,097 60,388 125,737 153,888
Physician
permanent
placement
services 8,328 8,907 7,715 16,043 19,861
$149,282 $199,140 $143,294 $292,576 $448,735
======== ======== ======== ======== ========
Reconciliation
of Non- GAAP
Items:
Segment Operating
Income(1)
Nurse and
allied
healthcare
staffing $7,250 $11,076 $8,734 $15,984 $25,798
Locum
tenens
staffing 6,399 10,154 5,471 11,870 14,807
Physician
permanent
placement
services 1,978 2,387 1,966 3,944 5,662
----- ----- ----- ----- -----
15,627 23,617 16,171 31,798 46,267
Unallocated
corporate
overhead 5,916 5,625 5,728 11,644 11,697
----- ----- ----- ------ ------
Adjusted
EBITDA(2) 9,711 17,992 10,443 20,154 34,570
Depreciation and
amortization 3,163 3,442 3,298 6,461 6,909
Stock- based
compensation 2,040 2,155 2,349 4,389 4,830
Acquisition
-related costs 1,094 - - 1,094 -
Impairment and
restructuring
charges - 2,152 - - 180,777
Interest
expense, net 2,583 2,320 2,637 5,220 4,519
----- ----- ----- ----- -----
Income (loss)
before income
taxes 831 7,923 2,159 2,990 (162,465)
Income tax
expense (benefit) 694 3,549 1,379 2,073 (45,005)
Net income (loss) $137 $4,374 $780 $917 $(117,460)
==== ====== ==== ==== =========
GAAP based
diluted net
income (loss)
per share (EPS) $- $0.13 $0.03 $(3.60)
Adjustments:
Acquisition
-related
costs 0.02 0.02
Impairment
and
restructuring
charges 0.04 3.86
Non-recurring
legal expense 0.02
Adjusted diluted
earnings per
share (3) $0.02 $0.17 $0.05 $0.28
===== ===== ===== =====
Three Months Ended Six Months Ended
------------------ ----------------
June 30, March 31, June 30,
-------- -------- --------
2010 2009 2010 2010 2009
Gross Margin
Nurse and
allied
healthcare
staffing 25.5% 25.0% 26.3% 25.9% 23.8%
Locum
tenens
staffing 26.2% 26.1% 26.2% 26.2% 26.2%
Physician
permanent
placement
services 56.9% 58.8% 57.9% 57.4% 60.3%
Operating Data:
---------------
Nurse and allied
healthcare staffing
Average
travelers
on
assignment
(4) 2,475 3,661 2,505 2,490 4,575
Revenue
per
traveler
per
day (5) $335.65 $333.59 333.51 334.59 $332.08
Gross
profit
per
traveler
per
day (5) $85.66 $83.36 87.68 86.67 $78.99
Locum tenens
staffing
Days
filled (6) 46,456 54,708 43,065 89,521 107,105
Revenue
per day
filled
(6) $1,406.66 $1,445.80 1,402 1,404.55 $1,436.80
Gross
profit
per
day
filled (6) $368.89 $377.79 367.08 368.02 $375.94
As of June 30 As of March 31,
------------- ---------------
2010 2009 2010
Leverage ratio (7) 2.5 1.1 2.1
(1) Segment Operating Income represents net income (loss) plus interest
expense (net of interest income), income taxes, depreciation and
amortization, impairment and restructuring charges, unallocated
corporate expenses, and stock-based compensation expense. Management
believes that Segment Operating Income is an industry wide financial
measure that is useful both to management and investors when
evaluating the company's performance. Management also uses Segment
Operating Income for planning purposes. Segment Operating Income is
not necessarily comparable to other similarly titled captions of
other companies due to potential inconsistencies in the method of
calculation and allocation of costs.
(2) Adjusted EBITDA represents net income (loss) plus interest expense
(net of interest income), income taxes, depreciation and
amortization, acquisition-related costs, impairment and restructuring
charges, and stock-based compensation expense. Management presents
adjusted EBITDA because it believes that adjusted EBITDA is a useful
supplement to net income as an indicator of operating performance.
Management believes that adjusted EBITDA is an industry wide
financial measure that is useful both to management and investors
when evaluating the company's performance. Management also uses
adjusted EBITDA for planning purposes. Management uses adjusted
EBITDA to evaluate the company's performance because it believes that
adjusted EBITDA provides an effective measure of the company's
results, as it excludes certain items that management believes are
not indicative of the company's operating performance and considers
measures used in credit facilities. However, adjusted EBITDA is not
intended to represent cash flows for the period, nor has it been
presented as an alternative to income (loss) from operations or net
income (loss) as an indicator of operating performance, and it should
not be considered in isolation or as a substitute for measures of
performance prepared in accordance with GAAP. As defined, adjusted
EBITDA is not necessarily comparable to other similarly titled
captions of other companies due to potential inconsistencies in the
method of calculation. While management believes that some of the
items excluded from adjusted EBITDA are not indicative of the
company's operating performance, these items do impact the income
statement, and management therefore utilizes adjusted EBITDA as an
operating performance measure in conjunction with GAAP measures such
as net income.
(3) Adjusted EPS represents GAAP EPS plus acquisition-related costs,
restructuring and impairment charges and non-recurring legal
expenses. Management presents adjusted EPS because it believes that
adjusted EPS is a useful supplement to diluted net loss per share as
an indicator of operating performance. Management believes such a
measure provides a picture of the company's results that is more
comparable among periods since it excludes the impact of items that
may recur occasionally, but tend to be irregular as to timing,
thereby distorting comparisons between periods. However, investors
should note that this non-GAAP measure involves judgment by
management (in particular, judgment as to what is classified as a
special item to be excluded from adjusted EPS). As defined, adjusted
EPS is not necessarily comparable to other similarly titled captions
of other companies due to potential inconsistencies in the method of
calculation. While management believes that some of the items
excluded from adjusted EPS are not indicative of the company's
operating performance, these items do impact the income statement,
and management therefore utilizes adjusted EPS as an operating
performance measure in conjunction with GAAP measures such as GAAP
EPS.
(4) Average travelers on assignment represents the average number of
nurse and allied healthcare professionals on assignment during the
period presented.
(5) Revenue per traveler per day and gross profit per traveler per day
represent the revenue and gross profit of the company's nurse and
allied healthcare staffing segment divided by average travelers on
assignment, divided by the number of days in the period presented.
(6) Days filled is calculated by dividing the locum tenens hours filled
during the period by 8 hours. Revenue per day filled and gross profit
per day filled represent revenue and gross profit of the company's
locum tenens staffing segment divided by days filled for the period
presented.
(7) Leverage ratio represents the ratio of the total debt outstanding at
the end of the period to the Adjusted EBITDA for the past twelve
months.
AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
June 30, March 31, December 31,
2010 2010 2009
---- ---- ----
Assets
Current assets:
Cash and cash equivalents $41,368 $36,567 $27,053
Accounts receivable, net 89,746 89,085 89,150
Accounts receivable, subcontractor 7,309 4,624 348
Prepaid expenses 6,595 7,152 6,550
Income taxes receivable 2,666 2,735 3,900
Deferred income taxes, net 8,534 8,534 8,534
Other current assets 1,209 1,415 1,902
----- ----- -----
Total current assets 157,427 150,112 137,437
Restricted cash and cash equivalents 20,961 22,022 22,025
Fixed assets, net 17,103 18,538 19,970
Deposits and other assets 13,898 14,432 14,368
Goodwill 79,868 79,868 79,868
Intangible assets, net 112,947 114,135 115,336
------- ------- -------
Total assets $402,204 $399,107 $389,004
======== ======== ========
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued
expenses $28,294 24,493 18,057
Accrued compensation and benefits 27,405 28,178 24,054
Current portion of notes payable 8,250 6,875 5,500
Deferred revenue 6,018 5,158 5,084
Other current liabilities 9,055 10,042 10,404
----- ------ ------
Total current liabilities 79,022 74,746 63,099
Notes payable, less current portion
and discount 95,317 97,721 100,121
Deferred income taxes, net 406 - 789
Other long-term liabilities 52,488 52,664 54,151
------ ------ ------
Total liabilities 227,233 225,131 218,160
------- ------- -------
Stockholders' equity 174,971 173,976 170,844
------- ------- -------
Total liabilities and stockholders'
equity $402,204 $399,107 $389,004
======== ======== ========
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Cash
Flows
(in thousands)
(unaudited)
Three Months Ended Six Months Ended
------------------ ----------------
June 30, March 31, June 30,
-------- --------- --------
2010 2009 2010 2010 2009
---- ---- ---- ---- ----
Net cash provided
by operating
activities $6,794 $36,388 $11,715 $18,509 $73,945
Net cash
provided by
(used in)
investing
activities 462 (1,204) (668) (206) (2,434)
Net cash used
in financing
activities (2,459) (28,420) (1,536) (3,995) (59,374)
Effect of
exchange
rates on
cash 4 49 3 7 35
--- --- --- --- ---
Net increase
in cash and
cash
equivalents 4,801 6,813 9,514 14,315 12,172
Cash and cash
equivalents
at beginning
of period 36,567 16,675 27,053 27,053 11,316
------ ------ ------ ------ ------
Cash and cash
equivalents
at end of
period $41,368 $23,488 $36,567 $41,368 $23,488
======= ======= ======= ======= =======